Related Experiment Video
Updated: Jun 28, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
Published on: July 7, 2013
Bailout Renal Stenting Associated With Endovascular Aortic Repair: A Single Centre Experience
Alba Alonso Pastor1, Francisco Abril Ramiro1, Paloma Alonso Diego1
1Vascular Surgery Department, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.
Introduction:
This study describes the midterm results of renal stenting as a bailout technique during endovascular aortic repair (EVAR) of abdominal aortic aneurysms.
Method:
A single centre retrospective study of renal artery rescue procedures during consecutive elective EVARs was performed in patients without pre-existing renal stenosis over a 22 year period. Demographic characteristics, aneurysm neck morphometry surgical details, technical success, peri-operative complications, re-interventions, renal function, and death during follow up were analysed.
Results:
Seven renal stents were implanted (all men; mean age 72.3 ± 7 years) in 748 EVARs (0.9%) in the study period. Two of seven (29%) patients had chronic kidney disease before the intervention. Two of seven (29%) aortic necks fulfilled hostility criteria (one case of conical neck and one case with a diameter >28 mm at renal level). The Herculink Elite (Abbott, Chicago, IL, USA) stent was used in all patients (seven of seven) (median length 18 mm, median diameter 6.14 ± 0.7 mm). Technical success was 100%, with no complications associated with the renal stenting and no peri-operative death. The two patients with chronic kidney disease presented with worsened renal function (creatinine 2.72 ± 3 mg/dL, glomerular filtration rate 62.3 ± 32) a median 17 months after the intervention, with no renal replacement therapy requirements during follow up. The renal stent patency rate was 100% after a median follow up of 21 months (range 6-92 months); no cases of renal infarction were identified on follow up imaging.
Conclusion:
The need for bailout renal stenting during EVAR was low in this cohort. It is essential to adopt all measures that guarantee precise endograft deployment, even in favourable anatomies.

